Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Coercion
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Does the Use of Botulinum Toxin in Treatment of Myofascial Pain Disorder of the Masseters and Temporalis Muscles Reduce Pain, Improve Function, or Enhance Quality of Life?
Placental expression of angiogenic factors in Trisomy 13.
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology. 2008 Jul 08; 71(2):136-44.
View in:
PubMed
subject areas
Adrenal Cortex Hormones
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Anti-Inflammatory Agents
Atrophy
Brain
Cladribine
Glatiramer Acetate
Humans
Immunoglobulins, Intravenous
Interferon-beta
Multiple Sclerosis
Natalizumab
Organ Size
Peptides
authors with profiles
Anthony Reder